Forte Biosciences (FBRX)

• Market cap: $161M
• 1 day: -2.49%
• 5 days: 5.63%
• 1 month: -13.73%
• 3 months: 29.66%
• 6 months: 77.26%
• Year to date: -48.79%
• 1 year: 190.79%
• 5 years: -98.67%
• 10 years: -99.72%
• Sector: Healthcare
• Industry: Biotechnology

About: Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).

Employees: 17